What are the standard forms of treatment for prostate cancer?
Dr. Lieberman: Radical prostatectomy, cryotherapy, surgical castration, external bean radiation therapy, brachytherapy, luteinizing hormone releasing hormone therapy, and combined androgen blockage have all been used. These treatments, however, are associated with numerous side effects, the most common being impotence. Radiation therapy also is associated with the development of “secondary cancer.” Consequently, many men prefer the concept of “watchful waiting” to other standard treatments. VRP: What can be done nutritionally to support conventional prostate cancer treatments? Dr. Lieberman: Poly-MVA is an excellent choice both for men who choose the “watchful waiting” approach and men who want nutritional support as an adjuvant to standard treatment. VRP: Poly-MVA is said to have a particularly interesting mechanism of action. Can you describe this? Dr. Lieberman: It actually has two proposed mechanisms of action. Poly-MVA is comprised of an irreversibly bound trimer of lipoic acid an
The treatment of prostate cancer depends upon a variety of factors, including the age and general health status of the patient, the stage and grade of the cancer, and the precise results of various prognostic tests now available. Four forms of patient management are considered to be “standard practice.” The first is commonly called “watchful waiting,” but might be better described as “active surveillance.” In this situation, no actual treatment is given to the patient, but the progression of his disease is carefully and regularly monitored using PSA tests and other forms of prognostic assessment. Such active surveillance is considered by many physicians to be particularly appropriate for prostate cancer patients diagnosed late in life whose prostate cancer is thought to be unlikely to progress to a serious clinical stage during the remainder of the patient’s lifetime. Two forms of therapy are considered standard options for the treatment of cancer that is entirely confined to the prost
Dr. Lieberman: Radical prostatectomy, cryotherapy, surgical castration, external bean radiation therapy, brachytherapy, luteinizing hormone-releasing hormone therapy, and combined androgen blockage have all been used. These treatments, however, are associated with numerous side effects, the most common being impotence. Radiation therapy also is associated with the development of secondary cancer. Consequently, many men prefer the concept of “watchful waiting” to other standard treatments. FACR: What can be done nutritionally to support conventional prostate cancer treatments? Dr. Lieberman: Poly-MVA is an excellent choice both for those who choose the “watchful waiting” approach and those that want nutritional support as an adjuvant to standard treatment. FACR: Poly-MVA is said to have a particularly interesting mechanism of action. Can you describe this? Dr. Lieberman: It actually has a two-step process for its mechanisms of action. Poly-MVA is comprised of an irreversibly bound trime
